Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
04/2000
04/13/2000CA2345377A1 Novel secreted proteins and polynucleotides encoding them
04/13/2000CA2345209A1 Antisense modulation of integrin .alpha.4 expression
04/13/2000CA2345045A1 G-protein coupled receptor proteins
04/13/2000CA2344973A1 Oxidoreductase molecules
04/13/2000CA2344269A1 Therapeutically active proteins in plants
04/13/2000CA2344266A1 Cadherin-like asymmetry protein-1, and methods for its use
04/13/2000CA2341374A1 Quinoline and quinazoline derivatives and their use as inhibitors of cytokine mediated diseases
04/12/2000EP0992581A2 Immunodominant human T-cell epitopes of hepatitis C virus
04/12/2000EP0992580A2 Immunodominant human T-cell epitopes of Hepatitis C virus
04/12/2000EP0992579A1 Stem cell factor
04/12/2000EP0992493A1 Substituted benzoylpiperidine derivatives and their use as Neurokinin antagonists
04/12/2000EP0992492A1 Small molecule inhibitors of rotamase enzyme activity
04/12/2000EP0992243A1 Prophylactic/remedial agent
04/12/2000EP0991767A1 Attenuated recombinant mycobacteria useful as immunogens or as vaccine components
04/12/2000EP0991758A1 Smad6 and uses thereof
04/12/2000EP0991665A1 Peptides and compounds that bind to the il-5 receptor
04/12/2000EP0991660A1 Deuterated cyclosporine analogs and their use as immunomodulating agents
04/12/2000EP0991653A1 Novel compounds
04/12/2000EP0991630A1 Crystalline roxifiban
04/12/2000EP0991321A1 Tolerance to natural antibody antigens
04/12/2000CN1250450A Novel pyrimidine derivative
04/12/2000CN1250445A Sulfamide-metalloprotease inhibitors
04/12/2000CN1250378A Pharmaceutical compositions
04/12/2000CN1250377A Hydrophilic binary systems for the administration of cyclosporine
04/12/2000CN1250370A Aqueous suspension for nasal administration of loteprednol
04/12/2000CN1250048A Substituted benzamides compound
04/12/2000CN1249942A Health oral liquid and its preparation
04/11/2000US6048972 Polynucleotide sequences which code for reshaped human monoclonal antibody preferential to interleukins
04/11/2000US6048962 Mammalian protein allergen; for the diagnosis and treatment of mammalian allergic response
04/11/2000US6048898 Synthesis of glatiramer acetate (copolymer-1)
04/11/2000US6048880 Therapy for cytokine sensitive diseases
04/11/2000US6048873 Skin disorders
04/11/2000US6048870 Mannosidase inhibitor; immunostimulant
04/11/2000US6048866 Substituted 2-anilinopryimidines useful as protein kinase inhibitors
04/11/2000US6048844 Treatment of conditions and disease
04/11/2000US6048724 Producing mammalian transfected cell strain which expresses exogenous dna encoding erythropoietin and glucagons; for prevention or treatment of a condition in which insulin production or glucagon function is defective
04/11/2000US6048716 Microorganism polypeptide; for infection prevention bactericides; wound healing agents
04/11/2000US6048535 Multivalent in ovo avian vaccine
04/11/2000US6048531 Immunogenic composites capable of stimulating production of anti-peptide antibodies, pharmaceutical compositions employing these composites and methods of selectively inducing production of anti-peptide antibodies
04/11/2000US6048530 Inducing cytotoxic t-cell response against viruses, bacteria, fungi, and parasites; immunology
04/11/2000US6048529 PVA or PEG conjugates of peptides for epitope-specific immunosuppression
04/11/2000US6048526 Monoclonal antibodies reactive with defined regions of the T cell antigen receptor
04/11/2000US6048525 Implanting hematopoietic cells comprising t-lymphocyte with dna sequence that expresses thymidine kinase gene; administering ganciclovir or acyclovir; treating graft versus host disease
04/11/2000US6048524 In vivo production and delivery of erythropoietin for gene therapy
04/11/2000US6048523 Polyester cyclic compounds, their complexes and bonded bodies
04/11/2000CA2182086C Use of mometasone furoate for treating airway passage and lung diseases
04/11/2000CA2129995C Piperidinyl thiacyclic derivatives
04/11/2000CA2007261C Novel tetralin derivatives
04/11/2000CA1340955C Stilbene derivatives
04/08/2000CA2285120A1 Heterocycles
04/06/2000WO2000018959A1 Trex, a novel gene of traf-interacting ext gene family and diagnostic and therapeutic uses thereof
04/06/2000WO2000018933A1 Immunotherapy of cancer through expression of truncated tumor or tumor-associated antigen
04/06/2000WO2000018919A1 Human kinesin-like motor protein
04/06/2000WO2000018915A2 Membrane-associated organizational proteins
04/06/2000WO2000018896A1 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon
04/06/2000WO2000018895A1 Short peptides which selectively modulate the activity of protein kinases
04/06/2000WO2000018888A1 Immunomodulation by genetic modification of dendritic cells and b-cells
04/06/2000WO2000018796A2 Secretory protein- zsig48
04/06/2000WO2000018795A2 Compositions and methods for wt1 specific immunotherapy
04/06/2000WO2000018794A1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
04/06/2000WO2000018760A1 1,3-benzodiazepines with integrin inhibitory activity for use in the treatment of inflammatory disorders
04/06/2000WO2000018759A1 Phenylalanine derivatives as alpha 4 integrin inhibitors
04/06/2000WO2000018744A1 Oxazole compounds as prostaglandin e2 agonists or antagonists
04/06/2000WO2000018738A1 Benzamide derivatives and their use as cytokine inhibitors
04/06/2000WO2000018735A1 2-substituted heterocyclic sulfonamides
04/06/2000WO2000018733A1 Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals
04/06/2000WO2000018438A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof
04/06/2000WO2000018435A1 Time-staggered utilization of tumor cells in combination with intact antibodies for immunization
04/06/2000WO2000018434A1 Mutant cholera holotoxin as an adjuvant
04/06/2000WO2000018433A2 Use of antigenic complexes of hiv envelope and hla class i antigens as hiv vaccine
04/06/2000WO2000018431A1 Chemokine receptor peptide vaccines for treatment and prevention of diabetes
04/06/2000WO2000018409A1 Use of certain drugs for treating nerve root injury
04/06/2000WO2000018398A1 Pharmaceutically active compounds and methods of use thereof
04/06/2000WO2000006588B1 STEREOISOMERS OF CpG OLIGONUCLEOTIDES AND RELATED METHODS
04/06/2000WO2000001671A3 Antihistaminic piperidine derivatives and intermediates for the preparation thereof
04/06/2000WO1999064596A3 Proteins regulating gene expression
04/06/2000WO1999064584A3 Protein for regulating apoptosis
04/06/2000WO1999061618A3 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
04/06/2000WO1999061056A3 Methods and products for inducing mucosal immunity
04/06/2000WO1999061013A3 COMPOUNDS HAVING IgE AFFECTING PROPERTIES
04/06/2000WO1999057144A3 Human transcriptional regulator molecules
04/06/2000WO1999040113A3 Lipopeptides containing an interferon fragment and uses thereof in pharmaceutical compositions
04/06/2000CA2794705A1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
04/06/2000CA2714449A1 Use of certain drugs for treating nerve root injury
04/06/2000CA2368856A1 Immunotherapy of cancer through expression of truncated tumor or tumor-associated antigen
04/06/2000CA2345978A1 Chemokine receptor peptide vaccines for treatment and prevention of diabetes
04/06/2000CA2345474A1 Oxazole compounds as prostaglandin e2 agonists or antagonists
04/06/2000CA2345273A1 Pharmaceutically active compounds and methods of use thereof
04/06/2000CA2344712A1 Secretory protein- zsig48
04/06/2000CA2344658A1 Human kinesin-like motor protein
04/06/2000CA2344578A1 Polistinae venom phospholipase
04/06/2000CA2344466A1 Use of antigenic complexes of hiv envelope and hla class i antigens as hiv vaccine
04/06/2000CA2343934A1 Short peptides which selectively modulate the activity of protein kinases
04/06/2000CA2343929A1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
04/06/2000CA2343696A1 Membrane-associated organizational proteins
04/06/2000CA2343656A1 Trex, a novel gene of traf-interacting ext gene family and diagnostic and therapeutic uses thereof
04/06/2000CA2340454A1 Benzamide derivatives and their use as cytokine derivatives
04/06/2000CA2338442A1 Phenylalanine derivatives as alpha 4 integrin inhibitors
04/06/2000CA2311462A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof
04/05/2000EP0990440A1 Drug composition
1 ... 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 ... 1172